Lv2
166 积分 2021-04-28 加入
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial
24天前
已完结
GLP-1 RA联合胰岛素治疗T2DM专家共识（2025版）
1个月前
已完结
Prevalence and Treatment of Diabetes in China, 2013-2018
3个月前
已完结
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
3个月前
已完结
Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults
4个月前
已完结
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
4个月前
已完结
中国家族性高乳糜微粒血症患者的临床特征及诊断标准探索.
5个月前
已完结
家族性乳糜微粒血症综合征的研究进展
5个月前
已完结
皖公网安备34019202002308
